Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transvascular drug delivery in solid tumors

F Yuan1

  • 1Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Seminars in Radiation Oncology
|June 20, 1998
PubMed
Summary

Tumor microvessels are more permeable to therapeutics than normal vessels due to large pores. Understanding this vascular barrier is key for developing new drug delivery strategies to tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Molecular epidemiological characteristics of human coronavirus NL63 in Shanghai City from 2019 to 2024].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2025
Same author

Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

[Analysis of discordant results between multiplex fluorescence PCR-capillary electrophoresis for microsatellite instability (MSI) detection and immunohistochemistry (IHC) for mismatch repair (MMR) protein expression in gastrointestinal adenocarcinoma].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2025
Same author

MFSnet: a multi-scale feature screening network for chicken counting in dense environments.

British poultry science·2025
Same author

Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis.

Scandinavian journal of rheumatology·2024

Area of Science:

  • Oncology
  • Vascular Biology
  • Drug Delivery

Background:

  • The tumor microvessel wall acts as a barrier, hindering therapeutic agent delivery to cancer cells.
  • Tumor microvessels exhibit increased permeability to macromolecules compared to normal vasculature, attributed to cytokine-induced large pore structures.

Purpose of the Study:

  • To investigate the characteristics of the tumor vascular barrier and its impact on therapeutic delivery.
  • To explore the factors influencing vascular permeability in tumors and its dynamic nature.

Main Methods:

  • Transport studies utilizing nanoparticles to determine tumor-specific cutoff pore sizes.
  • Analysis of the physicochemical properties of molecules and the ultrastructure of the vessel wall.
  • Examination of the tumor microenvironment's influence on vascular dynamics.

Main Results:

  • Vascular permeability in tumors is heterogeneous and dependent on molecular properties and vessel wall ultrastructure.
  • The cutoff pore size of tumor vasculature is tumor-specific.
  • Transvascular transport can dynamically alter the tumor microenvironment, affecting angiogenesis, blood flow, and interstitial pressure.

Conclusions:

  • The tumor vascular barrier presents significant challenges for drug delivery.
  • Further research is needed to elucidate barrier formation mechanisms.
  • Novel strategies are required to overcome or utilize the tumor vascular barrier for enhanced therapeutic efficacy.

Related Experiment Videos